Neoadjuvant therapy of camrelizumab combined with chemotherapy in patients (pts) with resectable esophageal squamous cell cancer (ESCC): Preliminary results of a preoperative phase exploratory clinical trial

被引：0
|
作者：
Dong, Y. [1 ,2 ]
Luo, J. [3 ]
Liu, S. [4 ]
Lin, Y. [5 ]
Han, H. [5 ]
机构：
[1] Shandong First Med Univ, Shandong Canc Hosp & Inst, Thorac Surg, Jinan, Peoples R China
[2] Shandong Acad Med Sci, Jinan, Peoples R China
[3] Shandong Canc Hosp, Oncol, Jinan, Peoples R China
[4] Shandong Univ, Thorac Surg, Shandong Canc Hosp, Jinan, Peoples R China
[5] Jiangsu Hengrui Pharmaceut Co Ltd, Dept Med, Jinan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1225P
引用
收藏
页码：S1109 / S1109
页数：1
相关论文
共 50 条
  • [41] A study of neoadjuvant sintilimab combined with triplet chemotherapy of lipo-paclitaxel, cisplatin, and S-1 for resectable esophageal squamous cell carcinoma (ESCC)
    Gu, Y.
    Chen, X.
    Wang, D.
    Ding, M.
    Xue, L.
    Zhen, F.
    Xu, J.
    Wang, M.
    Li, Y.
    Sun, N.
    Liu, C.
    Xu, L.
    Wang, Y.
    Luo, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S1307 - S1308
  • [42] CAMRELIZUMAB COMBINED WITH PACLITAXEL AND NEDAPLATIN AS NEOADJUVANT THERAPY FOR LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESPRIT): A PHASE II, SINGLE-ARM, EXPLORATORY RESEARCH
    Ma, Jianqun
    Zhang, Jinfeng
    Yang, Yingnan
    Zheng, Dayong
    Wang, Xiaoyuan
    Liang, Hao
    Zhang, Luquan
    Xin, Yanzhong
    Ling, Xiaodong
    Fang, Chengyuan
    Jiang, Hao
    Meng, Hongxue
    Zheng, Wei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A436 - A436
  • [43] Camrelizumab plus chemotherapy versus concurrent chemoradiotherapy as neoadjuvant therapy for resectable thoracic oesophageal squamous cell cancer (REVO): A multicenter, randomized, open-label, phase II trial
    Yuan, W. P.
    Chen, Y.
    Liu, J.
    Zhang, W.
    Chen, X.
    He, H.
    Chen, P.
    Lin, J-P.
    Zhang, D.
    Lin, H.
    Wei, W.
    Chen, W.
    Zhou, H.
    Gao, P.
    Liu, S.
    Wang, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S857 - S857
  • [44] GASC1-Adapted Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Prospective Clinical Biomarker Trial
    Jia, Ruinuo
    Mi, Youjia
    Yuan, Xiang
    Kong, Dejiu
    Li, Wanying
    Li, Ruonan
    Wang, Bingbing
    Zhu, Yafei
    Kong, Jinyu
    Ma, Zhikun
    Li, Na
    Mi, Qiangjian
    Gao, Shegan
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [45] Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first-line treatment of advanced esophageal squamous cell carcinoma
    Zhang, Bo
    Qi, Ling
    Wang, Xi
    Xu, Jianping
    Liu, Yun
    Mu, Lan
    Wang, Xingyuan
    Bai, Lidan
    Huang, Jing
    CANCER COMMUNICATIONS, 2020, 40 (12) : 711 - 720
  • [46] Chemotherapy plus camrelizumab versus chemotherapy alone as neoadjuvant treatment for resectable esophageal squamous cell carcinoma (ESCORT-NEO): A multi-center, randomized phase III trial.
    Li, Yin
    Qin, Jianjun
    Xue, Liyan
    Hao, Anlin
    Jiang, Tao
    Liu, Shuoyan
    Jiang, Hongjing
    Kang, Mingqiang
    Li, Hecheng
    Tian, Hui
    Fu, Junke
    Ma, Jianqun
    Fu, Maoyong
    Han, Yongtao
    Chen, Longqi
    Tan, Lijie
    Dai, Tianyang
    Liao, Yongde
    Zhang, Weiguo
    Li, Bin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : LBA244 - LBA244
  • [47] Safety and efficacy of camrelizumab combined with radiotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a prospective single-arm phase II clinical trial protocol
    Maohui Chen
    Yizhou Huang
    Shuliang Zhang
    Taidui Zeng
    Guanglei Huang
    Chun Chen
    Bin Zheng
    Trials, 24 (1)
  • [48] Safety and efficacy of camrelizumab combined with radiotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a prospective single-arm phase II clinical trial protocol
    Chen, Maohui
    Huang, Yizhou
    Zhang, Shuliang
    Zeng, Taidui
    Huang, Guanglei
    Chen, Chun
    Zheng, Bin
    TRIALS, 2023, 24 (01)
  • [49] [18F]AlF-NOTA-FAPI-04 PET/CT for Predicting Pathologic Response of Resectable Esophageal Squamous Cell Carcinoma to Neoadjuvant Camrelizumab and Chemotherapy: A Phase II Clinical Trial
    Dong, Yinjun
    Wang, Zhendan
    Hu, Xinying
    Sun, Yuhong
    Qin, Jingjie
    Qin, Qiming
    Liu, Shuguang
    Yuan, Shuanghu
    Yu, Jinming
    Wei, Yuchun
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (11) : 1702 - 1709
  • [50] Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): A phase., single-arm, exploratory research.
    Ma, Jianqun
    Zhang, Jinfeng
    Yang, Yingnan
    Zheng, Dayong
    Wang, Xiaoyuan
    Liang, Hao
    Zhang, Luquan
    Xin, Yanzhong
    Ling, Xiaodong
    Fang, Chengyuan
    Jiang, Hao
    Zheng, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345